[Clinical pharmacology of cholecystokinin--pancreozymin]. 1976

L I Geller

UI MeSH Term Description Entries
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L I Geller
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
L I Geller
July 1972, Horumon to rinsho. Clinical endocrinology,
L I Geller
January 1975, Horumon to rinsho. Clinical endocrinology,
L I Geller
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
L I Geller
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
L I Geller
February 1970, The American journal of digestive diseases,
L I Geller
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
L I Geller
February 1967, Nordisk medicin,
L I Geller
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!